ASPIRIN AND RISK OF BLEEDING IN PATIENTS WITH THROMBOCYTHEMIA

被引：40

作者：

BARBUI, T ^{[1
]}

BUELLI, M ^{[1
]}

CORTELAZZO, S ^{[1
]}

VIERO, P ^{[1
]}

DEGAETANO, G ^{[1
]}

机构：

[1] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY

来源：

AMERICAN JOURNAL OF MEDICINE | 1987年 / 83卷 / 02期

关键词：

D O I：

10.1016/0002-9343(87)90696-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：265 / 268

页数：4

共 11 条

[1]

BARBUI T, 1983, EUR J CANC CLIN ONCO, V19, P1043

[2]

BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185

[3]

CORTELAZZO S, 1980, THROMB HAEMOSTASIS, V43, P127

[4] RAPID, SENSITIVE MICROASSAY FOR PLATELET 5HT [J].

DRUMMOND, AH ;

GORDON, JL .

THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1974, 31 (02) :366-367

[5] BLEEDING TIME AS A SCREENING-TEST FOR EVALUATION OF PLATELET FUNCTION [J].

HARKER, LA ;

SLICHTER, SJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (04) :155-&

[6] UNCONTROLLED THROMBOCYTOSIS IN CHRONIC MYELOPROLIFERATIVE DISORDERS [J].

KESSLER, CM ;

KLEIN, HG ;

HAVLIK, RJ .

BRITISH JOURNAL OF HAEMATOLOGY, 1982, 50 (01) :157-167

[7]

LIVIO M, 1986, LANCET, V1, P414

[8] LOW-DOSE ASPIRIN AND INHIBITION OF THROMBOXANE B-2 PRODUCTION IN HEALTHY-SUBJECTS [J].

PATRONO, C ;

CIABATTONI, G ;

PINCA, E ;

PUGLIESE, F ;

CASTRUCCI, G ;

DESALVO, A ;

SATTA, MA ;

PESKAR, BA .

THROMBOSIS RESEARCH, 1980, 17 (3-4) :317-327

[9]

SCHAFER AI, 1984, BLOOD, V64, P1

[10] DEFICIENCY OF PLATELET LIPOXYGENASE ACTIVITY IN MYELOPROLIFERATIVE DISORDERS [J].

SCHAFER, AI .

NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (07) :381-386

← 1 2 →